Healthcare stocks rise following midterm election—roundup by Paige Minemyer Friday, November 9, 2018 A split Congress is good news for healthcare investors, plus more healthcare headlines.
Stanford Children’s names new CEO—roundup by Paige Minemyer Tuesday, November 6, 2018 Stanford Children’s Health has a new CEO, a labeling issue could delay treatment with EpiPens, plus more healthcare headlines.
Senior drug pricing official at HHS dies by Paige Minemyer Thursday, November 1, 2018 Dan Best, the official spearheading HHS' efforts to lower drug prices, has died, the agency announced on Thursday.
Pfizer manufacturing ills mean ongoing shortages for hospitals—roundup by Tina Reed Wednesday, October 31, 2018 Pfizer's ongoing manufacturing problems will continue to hit hospitals' injectable opioid supply and more healthcare headlines from around the web.
Worldwide C-section rates skyrocket—roundup by Paige Minemyer Friday, October 12, 2018 C-section rates worldwide have nearly doubled over the past decade, plus more healthcare headlines.
American Medical Association to back gun research—roundup by Tina Reed Wednesday, July 11, 2018 The AMA has announced a new partnership to support gun research as a public health issue, plus other healthcare headlines from around the web.
George W. Bush and Atul Gawande highlight AHIP keynotes by Matt Kuhrt Thursday, June 14, 2018 A conversation with George W. Bush and a session on end-of-life care with Atul Gawande highlight the this year's AHIP Institute and Expo keynotes.
Former CVS Health exec to oversee drug pricing reform at HHS by Matt Kuhrt Thursday, March 29, 2018 Former CVS Health executive Daniel Best and current HHS Administrator Brett Giroir, M.D., have been appointed to two new senior advisory roles at the agency.
Hospital opioid shortages lead to patient pain, medical errors by Pauline Bartolone, California Healthline Friday, March 16, 2018 A shortage of injectable opioid painkillers has left hospitals scrambling to find alternatives that may lead to dosage mistakes.
Meningitis B vaccine’s high price poses a healthcare conundrum by Shefali Luthra, Kaiser Health News Friday, September 8, 2017 Some physicians and other industry experts are growing uneasy about the role of marketing in leveraging parental fears to sell the MenB vaccine.
